Home/Filings/4/0001638643-26-000008
4//SEC Filing

O'Day Daniel Patrick 4

Accession 0001638643-26-000008

CIK 0000882095other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:46 PM ET

Size

6.7 KB

Accession

0001638643-26-000008

Research Summary

AI-generated summary of this filing

Updated

Gilead CEO Daniel O'Day Receives Award; 74,461 Shares Withheld

What Happened

  • Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), received 131,675 shares as a performance-based award on Feb 3, 2026 (reported as an acquisition at $0.00). On the same date 74,461 shares were withheld/disposed at $143.28 per share to satisfy tax withholding obligations, totaling approximately $10,668,772. The withholding is reported under transaction code F (tax payment/withholding).

Key Details

  • Transaction date: 2026-02-03; Form 4 filed 2026-02-05 (timely filing).
  • Award: 131,675 shares granted/acquired at $0.00.
  • Withholding/disposition: 74,461 shares at $143.28 each; total value ~$10,668,772.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote: The shares relate to performance share awards granted March 10, 2023 and March 10, 2024. Performance-vesting was certified; however, shares from the March 10, 2024 grant will not be issued until required continued service conditions are met.
  • Transaction code meaning: A = Award/Grant (acquisition); F = Payment of exercise price or tax liability (shares withheld to cover taxes).

Context

  • The 74,461-share disposition is a tax-withholding event tied to the award—not an open-market sale. Tax withholding on vested awards is common and does not necessarily indicate CEO selling for cash or signaling a view on the stock.
  • This was not an options exercise with an immediate open-market sale; it reflects compensation vesting mechanics and related tax payment.

Insider Transaction Report

Form 4
Period: 2026-02-03
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-03+131,675688,373 total
  • Tax Payment

    Common Stock

    2026-02-03$143.28/sh74,461$10,668,772613,912 total
Footnotes (1)
  • [F1]Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day|2026-02-05

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001638643

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:46 PM ET
Size
6.7 KB